Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
Yu-Qing Tan,1,2 Heng-Wen Chen,1,* Jun Li1,* 1Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, People’s Republic of China; 2Graduate School of Beijing University of Chinese Medicine, Beijing University of Chinese Medicine,...
Main Authors: | Tan YQ, Chen HW, Li J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-09-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/astragaloside-iv-an-effective-drug-for-the-treatment-of-cardiovascular-peer-reviewed-article-DDDT |
Similar Items
-
Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV
by: Zehui Xu, et al.
Published: (2023-12-01) -
A Preclinical Systematic Review and Meta-Analysis of Astragaloside IV for Myocardial Ischemia/Reperfusion Injury
by: Qun Zheng, et al.
Published: (2018-07-01) -
A Practical Quality Control Method for Saponins Without UV Absorption by UPLC-QDA
by: Manjia Zhao, et al.
Published: (2018-12-01) -
Astragaloside IV Suppresses Hepatic Proliferation in Regenerating Rat Liver after 70% Partial Hepatectomy via Down-Regulation of Cell Cycle Pathway and DNA Replication
by: Gyeong-Seok Lee, et al.
Published: (2021-05-01) -
Research on the interaction of astragaloside IV and calycosin in Astragalus membranaceus with HMGB1
by: Junyi Ye, et al.
Published: (2023-07-01)